Loading clinical trials...
Loading clinical trials...
Randomized Trial of Thymoglobulin Induction, Initial Tacrolimus, and Mycophenolate Mofetil Therapy With Steroid Avoidance in Primary Kidney Transplant Recipients Followed by Continued Tacrolimus/Mycophenolate Mofetil Therapy vs. Sirolimus/ Mycophenolate Mofetil Therapy
Conditions
Interventions
Sirolimus
Locations
1
United States
Mayo Clinic
Jacksonville, Florida, United States
Start Date
June 1, 2005
Primary Completion Date
September 1, 2008
Completion Date
September 1, 2008
Last Updated
July 31, 2012
NCT06656988
NCT04592640
NCT07094906
NCT07358572
NCT05099770
NCT06927024
Lead Sponsor
Mayo Clinic
Collaborators
Data Source & Attribution
This clinical trial information is sourced from ClinicalTrials.gov, a service of the U.S. National Institutes of Health.
Modifications: This data has been reformatted for display purposes. Eligibility criteria have been parsed into inclusion/exclusion sections. Location data has been geocoded to enable distance-based search. For the authoritative and most current information, please visit ClinicalTrials.gov.
Neither the United States Government nor Clareo Health make any warranties regarding the data. Check ClinicalTrials.gov frequently for updates.
View ClinicalTrials.gov Terms and Conditions